Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
NVST reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 represents the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-06 | +$0.88 (+3.36%) | $0.78 (2.98%) | -$2.78 (-10.27%) | $5.24 (19.38%) |
| 2026-02-05 | +$1.05 (+4.44%) | $1.38 (5.83%) | +$4.39 (+17.77%) | $2.54 (10.26%) |
| 2025-10-29 | -$0.08 (-0.40%) | $0.55 (2.77%) | +$0.16 (+0.80%) | $1.63 (8.16%) |
| 2025-07-31 | -$1.07 (-5.36%) | $0.86 (4.31%) | +$1.94 (+10.27%) | $1.19 (6.30%) |
| 2025-05-01 | +$0.26 (+1.62%) | $0.62 (3.82%) | +$0.65 (+3.98%) | $1.03 (6.30%) |
| 2025-02-05 | +$0.44 (+2.19%) | $0.66 (3.25%) | +$1.22 (+5.93%) | $1.62 (7.88%) |
| 2024-10-30 | +$0.44 (+2.34%) | $0.92 (4.90%) | +$1.74 (+9.05%) | $2.07 (10.76%) |
| 2024-08-07 | -$0.46 (-2.92%) | $0.90 (5.71%) | +$1.20 (+7.84%) | $1.41 (9.25%) |
| Avg Abs Move | 2.83% | 4.20% | 8.24% | 9.79% |
Historical price action around earnings reveals significant volatility, with an average absolute Day +1 move of 8.24% and trading range of 9.79% in the session following results. The most recent earnings release on May 6, 2026, exemplifies this pattern: the stock gained 3.36% on Day 0 in anticipation, then sold off sharply by 10.27% on Day +1 despite beating estimates, with an intraday range of 19.38%.
The February 2026 report showed the opposite dynamic—a 4.44% Day 0 gain followed by a powerful 17.77% surge on Day +1, the largest post-earnings rally in the dataset. This volatility underscores that NVST's post-earnings moves are driven more by guidance, commentary, and forward outlook than by the beat/miss itself. The average Day 0 move of 2.83% is relatively modest, but the Day +1 average of 8.24% with a 9.79% intraday range signals that investors should prepare for substantial price swings once the full earnings picture emerges.
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 17) |
| Expected Move | $0.30 (1.06%) |
| Expected Range | $27.66 to $28.26 |
| Implied Volatility | 70.89% |
The options market is pricing an expected move of 1.06% (±$0.30) through the August 21 expiration, implying a range of $27.66 to $28.26. This is dramatically lower than the 8.24% average historical Day +1 move, suggesting options traders are either underpricing earnings volatility or expecting a more muted reaction than NVST's recent history would indicate. The 17-day window to expiration and relatively low open interest of 750 contracts may be contributing to the compressed implied move.
Analyst sentiment on NVST reflects cautious optimism with a consensus rating of 3.82 (between Hold and Buy) based on 17 analysts. The current breakdown shows 7 Strong Buys, 0 Moderate Buys, 10 Holds, 0 Moderate Sells, and 0 Strong Sells—a distribution that suggests conviction among bulls but hesitation from a majority of the Street.
The average price target of $29.40 implies 5.2% upside from the current price of $27.96, with estimates ranging from a low of $21.00 to a high of $35.00. This relatively modest upside potential reflects the stock's recent strength—NVST has already rallied above all major moving averages heading into the report.
Sentiment has deteriorated over the past month, with the Hold count increasing from 9 to 10 while the average recommendation slipped from 3.88 to 3.82. This subtle shift suggests some analysts are taking a more cautious stance after the stock's recent run, possibly concerned about valuation or the sustainability of the growth trajectory. The wide range between the high and low price targets ($21.00 to $35.00) reflects meaningful disagreement about NVST's fair value, with bears seeing potential downside of 25% while bulls envision 25% upside from current levels.
NVST enters earnings with strong technical momentum, trading at $27.96 and positioned above all key moving averages: the 5-day ($27.76), 10-day ($27.13), 20-day ($26.75), 50-day ($25.64), 100-day ($25.63), and 200-day ($24.41). This alignment represents a bullish technical setup, with the stock having established a clear uptrend over multiple timeframes.
The Barchart Technical Opinion currently stands at 80% Buy, showing meaningful strengthening from 72% Buy one week ago and 56% Buy one month ago. This progressive improvement reflects building momentum as the stock has broken through resistance levels and attracted increased buying interest heading into the earnings release.
Timeframe Analysis:
Trend Characteristics: The trend is characterized as Average strength but Strengthening, indicating that while the move higher has been steady rather than explosive, momentum is building and the technical picture is improving as earnings approach.
The 200-day moving average at $24.41 represents a key support level 14.5% below current prices, providing a substantial cushion should the earnings reaction disappoint. The stock's position above all moving averages with strengthening momentum creates a supportive technical backdrop, though the medium-term signal's relative weakness (25% Buy) suggests some caution is warranted—a negative earnings surprise could trigger profit-taking from recent buyers.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $27.76 | 50-Day MA | $25.64 |
| 10-Day MA | $27.13 | 100-Day MA | $25.63 |
| 20-Day MA | $26.75 | 200-Day MA | $24.41 |
The technical setup heading into earnings is constructive but not without risk. The stock's position above all moving averages and the strengthening Barchart Opinion signal provide a supportive foundation, while the 50-day and 100-day averages clustered near $25.63 offer potential support zones. However, the medium-term signal's relative weakness and the stock's recent rally to $27.96 mean NVST has less room for disappointment—investors should be prepared for the 8-10% post-earnings swings that have characterized recent reports, with the 200-day average at $24.41 serving as a key downside reference point if results or guidance fall short.